These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8363777)
21. Perspectives for a protective HIV-1 vaccine. Schiavone M; Quinto I; Scala G Adv Pharmacol; 2008; 56():423-52. PubMed ID: 18086420 [No Abstract] [Full Text] [Related]
22. Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword. Füst G Vaccine; 2008 Jun; 26(24):2949-50. PubMed ID: 18321613 [No Abstract] [Full Text] [Related]
23. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection. Vieillard V; Costagliola D; Simon A; Debré P; AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720 [TBL] [Abstract][Full Text] [Related]
28. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. Musey LK; Krieger JN; Hughes JP; Schacker TW; Corey L; McElrath MJ J Infect Dis; 1999 Aug; 180(2):278-84. PubMed ID: 10395840 [TBL] [Abstract][Full Text] [Related]
29. Development of prophylactic AIDS vaccines: the current state of affairs. Hanke T Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467 [TBL] [Abstract][Full Text] [Related]
30. Measuring HIV-1-specific T cell immunity: how valid are current assays? D'Souza MP; Altfeld M J Infect Dis; 2008 Feb; 197(3):337-9. PubMed ID: 18184092 [No Abstract] [Full Text] [Related]
31. Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV. White A Med Hypotheses; 2008 Dec; 71(6):909-13. PubMed ID: 18768264 [TBL] [Abstract][Full Text] [Related]
32. HIV vaccine efficacy trials: towards the future of HIV prevention. Kim D; Elizaga M; Duerr A Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236 [TBL] [Abstract][Full Text] [Related]
33. AIDS vaccine development: the long and winding road. Garber DA; Feinberg MB AIDS Rev; 2003; 5(3):131-9. PubMed ID: 14598562 [TBL] [Abstract][Full Text] [Related]
34. [Immune control of HIV-infection and replication]. Matsushita S Uirusu; 2002 Jun; 52(1):77-82. PubMed ID: 12227184 [No Abstract] [Full Text] [Related]
36. Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop? Plummer FA; Ball TB; Kimani J; Fowke KR Immunol Lett; 1999 Mar; 66(1-3):27-34. PubMed ID: 10203031 [TBL] [Abstract][Full Text] [Related]
37. Basis of HIV resistance suggests new vaccine strategy. Senior K Lancet; 2001 May; 357(9268):1594. PubMed ID: 11377653 [No Abstract] [Full Text] [Related]